PREDICTION OF FUTURE SERUM CONCENTRATIONS WITH BAYESIAN FITTED PHARMACOKINETIC MODELS - RESULTS WITH DATA COLLECTED BY NURSES VERSUS TRAINED PHARMACY RESIDENTS

被引:12
作者
CHARPIAT, B
BREANT, V
PIVOTDUMAREST, C
MAIRE, P
JELLIFFE, R
机构
[1] USC,SCH MED,APPL PHARMACOKINET LAB,CSC 134-B,2250 ALCAZAR ST,LOS ANGELES,CA 90033
[2] CROIX ROUSSE HOSP,DEPT PHARM,LYON,FRANCE
[3] HOP DEBROUSSE,DEPT CLIN PEDIAT PHARMACOL,F-69005 LYON,FRANCE
[4] HOP EDOUARD HERRIOT,DEPT PHARM,F-69374 LYON 08,FRANCE
[5] ANTOINE CHARIAL HOSP,DEPT PHARM,ADCAPT,FRANCHVILLE,FRANCE
关键词
DATA COLLECTION; THERAPEUTIC DRUG MONITORING; TRAINED VERSUS UNTRAINED DATA COLLECTION; PRECISION OF PREDICTION;
D O I
10.1097/00007691-199404000-00010
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Recording the times of dosage administration and serum sampling by trained personnel resulted in significantly greater adherence to the protocol of therapeutic drug monitoring and in significantly greater precision in the achievement of desired serum concentration goals of aminoglycoside therapy than when relatively untrained personnel recorded it as a comparatively unemphasized part of their job. This was true even when only data of peak and trough serum concentrations were used. This study demonstrates that thoughtful data collection by appropriately trained nursing, pharmacy, or other clinical personnel is an essential part of therapeutic drug monitoring and plays a significant role in the optimal individualization of drug dosage regimens for patient care.
引用
收藏
页码:166 / 173
页数:8
相关论文
共 44 条
[1]   AN EVALUATION OF POPULATION PHARMACOKINETICS IN THERAPEUTIC TRIALS .3. PROSPECTIVE DATA-COLLECTION VERSUS RETROSPECTIVE DATA ASSEMBLY [J].
ANTAL, EJ ;
GRASELA, TH ;
SMITH, RB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (05) :552-559
[2]  
BAILEY N, 1961, STATISTICAL METHODS, P46
[3]  
BOSCH DE, 1990, CLIN PHARMACY, V9, P777
[4]  
BOTTGER HC, 1988, THER DRUG MONIT, V10, P280
[5]   A BAYESIAN FEEDBACK METHOD OF AMINOGLYCOSIDE DOSING [J].
BURTON, ME ;
BRATER, DC ;
CHEN, PS ;
DAY, RB ;
HUBER, PJ ;
VASKO, MR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (03) :349-357
[6]   A CONTROLLED TRIAL OF THE COST-BENEFIT OF COMPUTERIZED BAYESIAN AMINOGLYCOSIDE ADMINISTRATION [J].
BURTON, ME ;
ASH, CL ;
HILL, DP ;
HANDY, T ;
SHEPHERD, MD ;
VASKO, MR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (06) :685-694
[7]  
CHARPIAT B, 1989, THESIS U C BERNARD L
[8]   OPTIMAL SAMPLING TIMES FOR PHARMACOKINETIC EXPERIMENTS [J].
DARGENIO, DZ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (06) :739-756
[9]   IMPACT OF A CLINICAL PHARMACOKINETIC SERVICE ON PATIENTS TREATED WITH AMINOGLYCOSIDES - A COST-BENEFIT-ANALYSIS [J].
DESTACHE, CJ ;
MEYER, SK ;
BITTNER, MJ ;
HERMANN, KG .
THERAPEUTIC DRUG MONITORING, 1990, 12 (05) :419-426
[10]   DOES ACCEPTING PHARMACOKINETIC RECOMMENDATIONS IMPACT HOSPITALIZATION - A COST-BENEFIT-ANALYSIS [J].
DESTACHE, CJ ;
MEYER, SK ;
ROWLEY, KM .
THERAPEUTIC DRUG MONITORING, 1990, 12 (05) :427-433